Objectives, Symptoms, Mechanism of Action, Administration, Adverse Effects, Contraindications, Monitoring, Toxicity and Enhancing Health Care Team Outcomes of An Immuno Suppressive Drug Such as Cyclosporine

An immunosuppressive medication called cyclosporine is useful in treating organ rejection following transplantation. Additionally, it shows promise in treating organ rejection in kidney, liver, and heart allogeneic transplants, rheumatoid arthritis, and other autoimmune illnesses where methotrexate has not been effective enough. Also, it is a second-line agent for ALS and graft vs host disease. Other FDA-approved and non-FDA-approved indications are also present. For interprofessional team members treating illnesses where cyclosporine is recommended, this activity explains the drug's mechanism of action, adverse event profile, toxicity, dosage, pharmacodynamics, and monitoring.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-08-13
DOI
https://doi.org/10.5281/zenodo.21914059
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Objectives, Symptoms, Mechanism of Action, Administration, Adverse Effects, Contraindications, Monitoring, Toxicity and Enhancing Health Care Team Outcomes of An Immuno Suppressive Drug Such as Cyclosporine

Madhavi Latha C, Sony Sharlet E., U Renuka, Muralinath E. et al.
Zenodo (CERN European Organization for Nuclear Research)
Renal Transplantation Outcomes and Treatments
article

Objectives, Symptoms, Mechanism of Action, Administration, Adverse Effects, Contraindications, Monitoring, Toxicity and Enhancing Health Care Team Outcomes of An Immuno Suppressive Drug Such as Cyclosporine

Madhavi Latha C, Sony Sharlet E., U Renuka, Muralinath E., Guruprasad M., Karthik Jayanth Y., Sheethal U., Ramadevi Ch.
article en

Abstract

An immunosuppressive medication called cyclosporine is useful in treating organ rejection following transplantation. Additionally, it shows promise in treating organ rejection in kidney, liver, and heart allogeneic transplants, rheumatoid arthritis, and other autoimmune illnesses where methotrexate has not been effective enough. Also, it is a second-line agent for ALS and graft vs host disease. Other FDA-approved and non-FDA-approved indications are also present. For interprofessional team members treating illnesses where cyclosporine is recommended, this activity explains the drug's mechanism of action, adverse event profile, toxicity, dosage, pharmacodynamics, and monitoring.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 8%
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.